The Research and Development team at CARGO Therapeutics focuses on innovating and optimizing CAR T-cell therapies to overcome cancer treatment resistance. This includes discovering new biomarkers, translating research into clinical applications, advancing late-stage development, and ensuring manufacturing scalability and robustness for wider patient access to these potentially curative treatments.